Heather George
Family · Grinnell, IANPI 1407486194
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $825 of the $1,203 with a category attached, or 68.6%. Medical Device Business Services, Inc. accounts for 73.8% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $922 and has fallen 89.3% since, to $98 in 2025.
Across 21 payments — averaging $57.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$887
- Vertex$50
- Johnson & Johnson$44
- Pacira Pharmaceuticals Incorporated$36
- Smith+Nephew$36
- Stryker$34
- plus $115 from 6 others
What the payments were for
- Travel & lodging$82569%
- Food & beverage$37831%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 6 | $887 |
| Vertex | 3 | $50 |
| Johnson & Johnson | 2 | $44 |
| Pacira Pharmaceuticals Incorporated | 2 | $36 |
| Smith+Nephew | 1 | $36 |
| Stryker | 1 | $34 |
| Mauna Kea Technologies, Inc. | 1 | $27 |
| AbbVie | 1 | $23 |
| Novo Nordisk | 1 | $21 |
| Convatec Inc. | 1 | $17 |
| Vericel Corporation | 1 | $14 |
| CSL Behring | 1 | $13 |
How this compares
$1,203 in reported general payments places this provider in the 80th percentile of 1,268 family providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $251 |
| Oxycodone Hcl | 32 | $198 |
| Tramadol Hcl | 46 | $187 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $162 |
| Methylprednisolone | 22 | $133 |
| Ondansetron Hcl | 27 | $113 |
| Tizanidine Hcl | 16 | $60 |
| Meloxicam | 26 | $57 |
Paid to pharmacies, not to this prescriber.
Other family in Grinnell
- Stefanie GaticaAnkeny$354K
- Aubrey MolgaardAmes$238K
- Joan KittenFort Dodge$85K
- Megan FergusonPella$82K
- Rodney ClarkDes Moines$63K
- Jennifer CondonFort Dodge$31K
- Karen HunkeAmes$20K
- Tonia AckermanWest Des Moines$17K
- Chi-Ying SageWaterloo$14K
- Amanda GaldiNorth Liberty$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.